Rhumbline Advisers bought a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 7,369 shares of the company’s stock, valued at approximately $149,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. R Squared Ltd purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at about $30,000. Investment Research & Advisory Group Inc. purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at about $34,000. Compass Financial Services Inc purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at about $58,000. Virtu Financial LLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $279,000. Finally, Barclays PLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $311,000.
Guardian Pharmacy Services Stock Down 0.5 %
Shares of NYSE GRDN opened at $18.37 on Tuesday. Guardian Pharmacy Services, Inc. has a 52 week low of $14.16 and a 52 week high of $25.74. The company has a 50-day moving average of $20.49.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on GRDN
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Articles
- Five stocks we like better than Guardian Pharmacy Services
- How to Use the MarketBeat Stock Screener
- How to Protect Your Portfolio When Inflation Is Rising
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to trade using analyst ratings
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.